EFFECTIVENESS OF A PHARMACIST-DELIVERED SMOKING CESSATION PROGRAM IN THE STATE OF QATAR- A RANDOMIZED CONTROLLED TRIAL
Author(s)
El Hajj M1, Kheir N1, Al Mulla AM2, Shami R1, Fanous N3, Mahfoud Z4
1Qatar University College of Pharmacy, Doha, Qatar, 2Medicine Department Hamad Medical Corporation, Doha, Qatar, 3The University of Glasgow, Glasgow, UK, 4Weill Cornell Medicine- Qatar, Doha, Qatar
METHODS: A prospective randomized controlled trial was conducted in eight ambulatory pharmacies in Qatar. Eligible participants were smokers 18 years and older who smoked one or more cigarettes daily for 7 days, were motivated to quit, able to communicate in Arabic or English, and attend the program sessions. Intervention group participants met with the pharmacists four times at 2 to 4 week intervals. Participants in the control group received unstructured brief smoking cessation counseling. The primary study outcome was self-reported continuous abstinence at 12 months. Multinomial logistic regression model was fitted to assess the predictors of smoking at 12 months. Analysis was conducted using IBM-SPSS® version 23 and STATA® version 12.
RESULTS: A total of 314 smokers were randomized into two groups: intervention (n=167) and control (n=147). Smoking cessation rates were higher in the intervention group at 12 months; however this difference was not statistically significant (23.9% vs. 16.9% p=0.257). Nevertheless, the daily number of cigarettes smoked for those who relapsed was significantly lower (by 4.7 and 5.6 cigarettes at 3 and 6 months respectively) in the intervention group as compared to control group (p=0.041 and p=0.018 respectively). At 12 months, the difference was 3.2 cigarettes in favor of the intervention group but was not statistically significant (p=0.246). Years of smoking and daily number of cigarettes were the only predictors of smoking as opposed to quitting at 12 months (p= 0.005; p=0.027 respectively). CONCLUSIONS: There was no statistically significant difference in the smoking cessation rate at 12 months between the groups. However, the program led to higher (albeit non-significant) smoking cessation rates compared with usual care. More research should be conducted to identify factors that might improve abstinence.Conference/Value in Health Info
Value in Health, Vol. 20, No. 9 (October 2017)
Code
PHS10
Topic
Clinical Outcomes
Topic Subcategory
Comparative Effectiveness or Efficacy
Disease
Respiratory-Related Disorders